Skip to main content
SpringerLink
Log in

The motor circuit of the human basal ganglia reconsidered

  • Conference paper
Advances in Research on Neurodegeneration

Summary

The standard model of human basal ganglia organization was introduced in the 1980s on the basis of animal experiments and clinical experience of various human motor disorders. This paper reviews evidence from various sources which suggests that this standard model only incompletely accounts for aspects of basal ganglia function, and thus requires modification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albin R.L., Young A.B., Penney J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366–376

    Article  PubMed  CAS  Google Scholar 

  • Baron M.S., Vitek J.L., Bakay R.A.E., Green J, Kanecke Y, Hashimoto T, Turner R.S., Woodard J.L., McDonald W.M., DeLong M.R. (1996) Treatment of advanced Parkinson’s disease by GPi pallidotomy: 1 year pilot study results. Ann Neurol 40:355–366

    Article  PubMed  CAS  Google Scholar 

  • Baronti F, Mouradian M, Davis T.L., Guiffa M, Brughitta G, Conant K.E., Chase T.N. (1992) Lisuride effects on central dopaminergic mechanisms in Parkinson’s disease. Ann Neurol 32: 776–781

    Article  PubMed  CAS  Google Scholar 

  • Benabid A.L., Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, Laurent A, Gentil M, Perret J (1994) Acute and long-term effects of subthalamic nucleus stimulation in Parkinson’s disease. Stereotact Funct Neurosurg 62: 76–84

    Article  PubMed  CAS  Google Scholar 

  • Bergman H, Wichmann T, DeLong M.R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436–1438

    Article  PubMed  CAS  Google Scholar 

  • Bernard V, Gardiol A, Faucheux B, Bloch B, Agid Y, Hirsch E.C. (1996) Expression of glutamate receptors in the human and rat basal ganglia. Effect of the dopaminergic denervation on AMP A receptor gene expression in the striatopallidal complex in Parkinson’s disease and rat with 6-OHDA lesion. J Comp Neurol 368: 553–568

    Article  PubMed  CAS  Google Scholar 

  • Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlates. J Neurol Sci 20: 415–455

    Article  PubMed  CAS  Google Scholar 

  • Blanchet P.J., Boucher R, Bedard P.J. (1994) Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys. Brain Res 650:32–39

    Article  PubMed  CAS  Google Scholar 

  • Blandini F, Greenamyre J.T. (1995) Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia. Brain Res 669: 59–66

    Article  PubMed  CAS  Google Scholar 

  • Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221–226

    Article  PubMed  CAS  Google Scholar 

  • Chase T.N., Engber T.M., Mouradian M.M. (1996) Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson’s disease. Adv Neurol 69: 497–501

    PubMed  CAS  Google Scholar 

  • Chesselet M.F., Delfs J.M. (1996) Basal ganglia and movement disorders: an update. Trends Neurosci 19: 417–422

    PubMed  CAS  Google Scholar 

  • Danielczyk W (1973) Die Behandlung von akinetischen Krisen. Med Welt 24: 1278–1282

    PubMed  CAS  Google Scholar 

  • Féger J (1996) Letter: Updating the functional model of the basal ganglia. Trends Neurosci 20: 152–153

    Article  Google Scholar 

  • Fici G.J., von Voigtlander P.F., Sethy V.H. (1997) DJ dopamine receptor activity of antiparkinsonian drugs. Life Sci 60: 1597–1603

    Article  PubMed  CAS  Google Scholar 

  • Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 178: 425–441

    Article  Google Scholar 

  • Gerfen C.R., Engber T.M., Mahan L.C., Zvi S, Chase T.W., Monsma F.J., Sibley D.R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429–1432

    Article  PubMed  CAS  Google Scholar 

  • Gerlach M, Gsell W, Kornhuber J, Jellinger K, Krieger V, Pantucek F, Vock R, Riederer P (1996) A post mortem study on neurochemical markers of dopaminergic, GABAergic and glutamatergic neurons in basal ganglia-thalamo-cortical circuits in Parkinson syndrome. Brain Res 741: 142–152

    Article  PubMed  CAS  Google Scholar 

  • Hassani O.K., Mouroux M, Feger J (1996) Increased subthalamic neuronal activity after nigral dopamine lesion independent of disinhibition by the globus pallidus. Neurosci 72: 105–115

    Article  CAS  Google Scholar 

  • Herrero M.T., Augood S.J., Hirsch E.C., Javoy-Agid F, Luquin M.R., Agid Y, Obeso J.A., Emson P.C. (1995) Effects of L-dopa on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neurosci 68: 1189–1198

    Article  CAS  Google Scholar 

  • Herrero M.T., Levy R, Ruberg M, Luquin M.R., Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso J.A., Hirsch E.C. (1996a) Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47: 219–224

    Article  PubMed  CAS  Google Scholar 

  • Herrero M.T., Levy R, Ruberg M, Javoy-Agid F, Luquin M.R., Agid Y, Hirsch EC, Obeso J.A. (1996b) Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson’s disease. Adv Neurol 69: 209–216

    PubMed  CAS  Google Scholar 

  • Kincaid A.E., Penney J.B., Young A.B., Newman S.W. (1991) The globus pallidus receives a projection from the parafascicular nucleus in the rat. Brain Res 553: 18–26

    Article  PubMed  CAS  Google Scholar 

  • Krack P, Limousin P, Benabid A.L., Pollak P (1997) Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson’s disease. Lancet 350:1676

    Article  PubMed  CAS  Google Scholar 

  • Lange K.W., Kornhuber J, Riederer P (1997) Dopamine/glutamate interactions in Parkinson’s disease. Neurosci Biobehav Rev 21: 393–400

    Article  PubMed  CAS  Google Scholar 

  • Lees A.J., Stern G.M. (1981) Sustained bromocriptine therapy in previously untreated patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 44: 1020–1023

    Article  PubMed  CAS  Google Scholar 

  • Levy R, Herrero M.T., Ruberg M, Villares J, Faucheux B, Guridi J, Guillen J, Luquin M.R., Javoy-Agid F, Obeso J.A., Agid Y, Hirsch E.C. (1995a) Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons of the striatum in MPTP-treated monkeys and Parkinson’s disease: an in situ hybridization study of GAD67 mRNA. Eur J Neurosci 7: 1199–1209

    Article  PubMed  CAS  Google Scholar 

  • Levy R, Ruberg M, Herrero M.T., Villares J, Javoy-Agid F, Agid Y, Hirsch E.C. (1995b) Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. Neurology 45: 127–134

    Article  PubMed  CAS  Google Scholar 

  • Levy R, Vila M, Herrero M.T., Faucheux B, Agid Y, Hirsch E.C. (1995c) Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson’s disease. Neurosci Lett 199: 220–224

    Article  PubMed  CAS  Google Scholar 

  • Levy R, Hazrati L.N., Herrero M.T., Vila M, Hassani O.K., Mouroux M, Ruberg M, Asensi H, Agid Y, Feger J, Obeso J.A., Parent A, Hirsch E.C. (1997) Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience 76: 335–343

    Article  PubMed  CAS  Google Scholar 

  • Lieberman A.N., Goldstein M, Leibowitz M, Gopinatham G, Neophytide A, Hiesiger E, Nelson J, Walker R (1984) Long term treatment with pergolide: decreased efficacy with time. Neurology 34: 223–226

    Article  PubMed  CAS  Google Scholar 

  • Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas J.F., Broussolle E, Perrett J.E., Benabid A.L. (1995) Effects on parkinsonian signs and symptoms of bilateral subthalamic stimulation. Lancet 345: 91–95

    Article  PubMed  CAS  Google Scholar 

  • Marsden C.D., Obeso J.A. (1994) The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson’s disease. Brain 117: 887–897

    Article  Google Scholar 

  • Metman L.V., Del Dotto P, van den Munckhof P, Fang J, Mouradian M.M., Chase T.N. (1998a) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Neurology 50: 1232–1326

    Google Scholar 

  • Metman L.V., Del Dotto P, Blanchet P.J., van den Munckhof P, Chase T.N. (1998b) Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Amino Acids 14: 75–82

    Article  Google Scholar 

  • Miller W.C., DeLong M.R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter M.B., Jayaraman A (eds) The basal ganglia II. Structure and function: current concepts. Plenum Press, New York, pp 415–427

    Google Scholar 

  • Mitchell I.J., Clarke C.E., Boyce S, Robertson R.G., Peggs D, Sambrook M.A., Crossman A.R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyL-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci 32: 213–226

    Article  CAS  Google Scholar 

  • Müller W.E., Mutschler E, Riederer P (1995) Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer’s dementia. Pharmacopsychiatry 28: 113–124

    Article  PubMed  Google Scholar 

  • Page R.D., Sambrook M.A., Crossman A.R. (1993) Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-dihydropyridine-treated parkinsonian monkey. Neurosci 55: 147–165

    Article  CAS  Google Scholar 

  • Palacios J.M., Camps M, Cortes P, Probst A (1998) Mapping dopamine receptors in the human brain. J Neural Transm [Suppl] 27: 227–235

    Google Scholar 

  • Parent A, Cicchetti F (1998) The current model of basal ganglia organization under scrutiny. Mov Disord 13: 199–202

    Article  PubMed  CAS  Google Scholar 

  • Parent A, Hazrati L.N. (1995) Functional anatomy of the basal ganglia. I The cortico-basal ganglia-thalamo-corticalloop. Brain Res Rev 20: 91–127

    Article  PubMed  CAS  Google Scholar 

  • Parsons C.G., Panchenko V.A., Pinchenko V.O., Tsyndrenko A.Y., Krishtal O.A. (1996) Comparative patch-clamp study with freshly dissociated rat hippocampal and striatal neurons: antagonistic effects on the NMDA receptor of amantadine and memantine. Eur J Neurosci 8: 446–454

    Article  PubMed  CAS  Google Scholar 

  • Pearce R.K.B., Banerji T, Jenner P, Marsden C.D. (1998) De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTPtreated marmoset. Mov Disord 13: 234–241

    Article  PubMed  CAS  Google Scholar 

  • Pinter M.M., Alesch F, Murg M, Seiwald M, Helscher R.J., Binder H (1999) Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced Parkinson’s disease: one year follow-up. J Neural Transm 106: 693–709

    Article  PubMed  CAS  Google Scholar 

  • Porter R.H.P., Greene J.G., Higgins D.S., Greenamyre J.T. (1994) Polysnaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 14: 7192–7199

    PubMed  CAS  Google Scholar 

  • Rascol O, Blin O, Descombes S, Soubrouilliard C, Fabre N, Viallet F, Thalamas C, Azulay J.P., Lafnitzegger K, Fredrick E, Wright S, Nutt J (1997) ABT-431, a selective D1 agonist, has efficacy in patients with Parkinson’s disease (abstract). Neurology 48:32004

    Google Scholar 

  • Sadikot A.F., Parent A, François C (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections. J Comp Neurol 315: 137–159

    Article  PubMed  CAS  Google Scholar 

  • Sellal F, Hirsch E, Lisovoski F, Mutschler V, Collard M, Marasceux C (1992) Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 42:255–256

    Article  PubMed  CAS  Google Scholar 

  • Shiosaki K, Jenner P, Asin K.E., Britton D.R., Lin C.W., Michaelides M, Smith L, Bianchi B, Didomenico S, Hodges L, Hong Y.F., Mahan L, Mikusa J, Miller T, Nikkel A, Stashko M, Witte D, Williams M (1996) ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D-1 receptor agonist. In vitro characterization and effects in animal models of Parkinson’s disease. J Pharmacol Exp Ther 276: 150–160

    PubMed  CAS  Google Scholar 

  • Starr M.S. (1995) Glutamate/dopamine DlID2 balance in the basal ganglia and its relevance to Parkinson’s disease. Synapse 19: 264–293

    Article  PubMed  CAS  Google Scholar 

  • Tel B.C., Zeng B.Y., Pearce R.K.B., Rose S, Jenner P, Marsden C.D. (1999) Changes in striatal preproenkephalin (PPE-A) and preprotachykinin (PPT) mRNA expression: the effects of L-dopa, bromocriptine and ropinirole in MPTP-treated marmosets (Abstract).

    Google Scholar 

  • Vernier P, Julien J.F., Rataboul P, Fourrier O, Feuerstein C, Mallet J (1988) Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J Neurochem 51: 1375–1380

    Article  PubMed  CAS  Google Scholar 

  • Vila M, Levy R, Herrero M.T., Faucheux B, Obeso J.A., Agid Y, Hirsch E.C. (1996) Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neurosci 71: 903–912

    Article  CAS  Google Scholar 

  • Vila M, Levy R, Herrero M.T., Ruberg M, Faucheux B, Obeso J.A., Agid Y, Hirsch E.C. (1997) Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 17: 765–773

    PubMed  CAS  Google Scholar 

  • Wichmann T, DeLong M.R. (1996) Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6: 751–758

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstrasse 15, D-97080, Würzburg, Federal Republic of Germany

    P. Foley & Prof. P. Riederer

Authors
  1. P. Foley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan

    Y. Mizuno

  2. Neurodegenerative Disorders Centre, Faculty of Medicine, University Hospital, Vancouver, B.C., Canada

    D. B. Calne

  3. Clinical Research, Schering AG, Berlin, Federal Republic of Germany

    R. Horowski

  4. Department of Neurology, University of Innsbruck, Austria

    W. Poewe

  5. Department of Psychiatry, University of Würzburg, Federal Republic of Germany

    P. Riederer

  6. Rappaport Family Institute for Research in the Medical Sciences, Haifa, Israel

    M. B. H. Youdim

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Wien

About this paper

Cite this paper

Foley, P., Riederer, P. (2000). The motor circuit of the human basal ganglia reconsidered. In: Mizuno, Y., Calne, D.B., Horowski, R., Poewe, W., Riederer, P., Youdim, M.B.H. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6284-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6284-2_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7246-9

  • Online ISBN: 978-3-7091-6284-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation